Alnylam Pharmaceuticals, Inc. (ALNY)
332.92
+1.68
(+0.51%)
USD |
NASDAQ |
Feb 27, 16:00
332.74
-0.18
(-0.05%)
After-Hours: 20:00
Alnylam Pharmaceuticals Research and Development Expense (TTM) : 1.320B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 771.09M |
| Biogen, Inc. | 1.498B |
| Pfizer Inc. | 10.25B |
| Eli Lilly & Co. | 13.34B |
| AbbVie, Inc. | 9.096B |